Xenetic Biosciences Inc. (XBIO)
NASDAQ: XBIO
· Real-Time Price · USD
3.10
-0.14 (-4.32%)
At close: Jun 13, 2025, 3:28 PM
3.04
-1.94%
After-hours: Jun 13, 2025, 07:07 PM EDT
-4.32% (1D)
| Bid | 3.01 |
| Market Cap | 4.78M |
| Revenue (ttm) | 2.58M |
| Net Income (ttm) | -3.67M |
| EPS (ttm) | -2.38 |
| PE Ratio (ttm) | -1.3 |
| Forward PE | -0.7 |
| Analyst | n/a |
| Ask | 3.07 |
| Volume | 7,794 |
| Avg. Volume (20D) | 8,080 |
| Open | 3.01 |
| Previous Close | 3.24 |
| Day's Range | 3.00 - 3.22 |
| 52-Week Range | 2.20 - 5.20 |
| Beta | 2.29 |
About XBIO
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol XBIO
Website n/a
2 months ago · accessnewswire.com
Xenetic Biosciences, Inc. Releases Virtual Investor "What This Means" Segment- Dr. Reid Bissonnette, Executive Consultant for Translational Research and Development at Xenetic, discusses positive preclinical data recently presented at the Society for Immunotherapy of Cancer (S...
2 months ago · accessnewswire.com
Xenetic Biosciences, Inc. Reports Full Year 2024 Financial ResultsEncouraging preclinical data supporting the use of DNase-based technology to target NETosis and address difficult to treat cancers Strategic focus on exploratory investigator-initiated clinical studie...